国产人人色I色婷婷综合久久中文字幕雪峰I奇米色777欧美一区二区I久热久热aV爽青青在线I国产av喷水I国产伦精品一区二区三区免.费I高潮av在线Iww欧美一级I91天天看I黄a在线91I九一无码中文字幕久久无码色…I丰满国产精品视频二区

USEUROPEAFRICAASIA 中文雙語Fran?ais
Opinion
Home / Opinion / Opinion Line

All parties benefit from negotiated cuts in pharmaceutical drug prices

China Daily | Updated: 2017-08-09 07:40

All parties benefit from negotiated cuts in pharmaceutical drug prices

Customers shop for over-the-counter medicines at a drugstore in Yinchuan, Ningxia Hui autonomous region, in this file photo. [Photo/Xinhua]?


THE MINISTRY OF HUMAN RESOURCES AND SOCIAL SECURITY published the result of the price negotiations on 36 medicines. The end-user price of the drugs has decreased by 44 percent on average, compared with their retail price last year, and they have been listed on the drug directory of the national medical insurance system. Beijing Youth Daily comments:

It is noteworthy that 15 out of the 36 medicines treat cancers and the rest are drugs for cardiovascular disease, hemophilia, and other serious illness.

The remarkable drop in the prices of these medicines resulted from the negotiations between the government and the pharmaceutical companies, the first time such negotiations have taken place in China, and they will relieve the medical cost burden on patients.

There have long been calls for these expensive drugs to be covered by the national medical insurance fund. However, their previously high prices made it impossible for the fund to cover them.

Yet despite the decrease in the price of these medicines, the profits made by the pharmaceutical companies are unlikely to fall as the sales volume of the medicines now they are included in the medical insurance's drug directory will significantly increase.

The tangible benefits the negotiations have produced are well worth the difficult and protracted discussions between the two parties. The purpose of the price negotiation is to look for an equilibrium point that can balance the interests of the medical insurance fund, patients and the drug enterprises, so as to make the whole system more sustainable.

The inclusion of the drugs in the medical insurance coverage directly improves the quality of the system and meets the needs of patients.

The price negotiation organized by the public health authorities enhances the transparency of the medicine pricing mechanism, and removes the middlemen, setting a good example as a conventional practice for the future.

 

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US